Hormos Medical Corp.
This article was originally published in Start Up
With licenses and several scientists recruited from Finnish pharmaceutical firm Orion, Hormos Medical was formed to develop a platform of tissue-specific modulators of steroid hormones (such as androgen and estrogen) that addresses many of the diseases that arise from an age-related decrease in hormone levels.
You may also be interested in...
The topic of longevity has fascinated explorers since long before Ponce de Leon went looking for the fountain of youth. Today's explorations involve the study of genes and metabolic pathways in organisms that for some unknown reason live longer than their peers.
Wound Solutions Ltd. looks to the paradigm of patient self-care in diabetes to address the gaps in chronic wound care, where the feedback provided by blood glucose monitoring encourages changes in behavior. A small device that is placed under a compression bandage helps patients with venous leg ulcers comply with the steps they should be taking to support wound healing, in the process, collecting data that helps clinicians make informed therapy decisions.
The treatment of chronic wounds is challenging, not only because of the underlying biology, but also because of more practical considerations: fragmentation in the care settings, the logistics of delivering products to patients, and the costs of chronic care. Next generation advanced wound care companies are engineering solutions to these problems.